Centre of Imaging Diagnosis, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Int J Nanomedicine. 2019 Jun 19;14:4517-4528. doi: 10.2147/IJN.S199571. eCollection 2019.
We developed a contrast agent for targeting E-selectin expression. We detected the agent using magnetic resonance imaging (MRI) in vivo in nude mice that had undergone nasopharyngeal carcinoma (NPC) metastasis. Sialyl Lewis X (sLe) was conjugated with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Hydrodynamic size, polydispersity index, and ζ-potential of USPIO-polyethylene glycol (PEG) nanoparticles and USPIO-PEG-sLe nanoparticles were measured. Component changes in nanoparticles of USPIO, USPIO-PEG, and USPIO-PEG-sLe were analyzed by thermogravimetric analysis and Fourier-transform infrared spectroscopy. A model of NPC metastasis to inguinal lymph nodes in nude mice was used to investigate characteristics of the USPIO-PEG-sLe nanoparticles in vivo. We investigated the ability of the T2* value, change in T2* value (ΔT2* value), and enhancement rate (ER) to assess accumulation of USPIO-PEG-sLe nanoparticles quantitatively in mice of a metastasis group and control group. Four MRI scans were undertaken for each mouse. The first scan (t0) was done before administration of USPIO-PEG-sLe nanoparticles (0.1 mL) via the tail vein. The other scans were carried out at 0 (t1), 1 (t2), and 2 hours (t3) postinjection. The mean optical density was used to reflect E-selectin expression. sLe was labeled onto USPIO successfully. In vivo, there were significant interactions between the groups and time for T2* values after administration of USPIO-PEG-sLe nanoparticles. Six parameters (T2* at t2, ΔT2* at t1, ΔT2* at t2, ER at t1, ER at t2, and ER at t3) were correlated with the mean optical density. USPIO-PEG-sLe nanoparticles can be used to assess E-selectin expression quantitatively. Use of such molecular probes could enable detection of early metastasis of NPC, more accurate staging, and treatment monitoring.
我们开发了一种针对 E-选择素表达的靶向造影剂。我们使用磁共振成像 (MRI) 在经历鼻咽癌 (NPC) 转移的裸鼠体内检测到了该造影剂。唾液酸化路易斯 X (sLe) 与超顺磁性氧化铁 (USPIO) 纳米颗粒偶联。测量了 USPIO-聚乙二醇 (PEG) 纳米颗粒和 USPIO-PEG-sLe 纳米颗粒的水动力粒径、多分散指数和 ζ 电位。通过热重分析和傅里叶变换红外光谱分析了 USPIO、USPIO-PEG 和 USPIO-PEG-sLe 纳米颗粒的成分变化。使用裸鼠 NPC 转移至腹股沟淋巴结的模型研究了 USPIO-PEG-sLe 纳米颗粒在体内的特性。我们研究了 T2* 值、T2* 值变化 (ΔT2* 值) 和增强率 (ER) 的能力,以定量评估转移组和对照组小鼠中 USPIO-PEG-sLe 纳米颗粒的积累情况。对每只小鼠进行了 4 次 MRI 扫描。第一次扫描 (t0) 在尾静脉注射 USPIO-PEG-sLe 纳米颗粒 (0.1 mL) 之前进行。其他扫描分别在注射后 0 小时 (t1)、1 小时 (t2) 和 2 小时 (t3) 进行。平均光密度用于反映 E-选择素表达。sLe 成功标记到 USPIO 上。在体内,USPIO-PEG-sLe 纳米颗粒给药后 T2* 值的组间和时间存在显著相互作用。六个参数 (t2 时的 T2*、t1 时的 ΔT2*、t2 时的 ΔT2*、t1 时的 ER、t2 时的 ER 和 t3 时的 ER) 与平均光密度相关。USPIO-PEG-sLe 纳米颗粒可用于定量评估 E-选择素表达。此类分子探针的使用可以实现 NPC 早期转移的检测、更准确的分期和治疗监测。